144 related articles for article (PubMed ID: 27625019)
1. Subpathway-CorSP: Identification of metabolic subpathways via integrating expression correlations and topological features between metabolites and genes of interest within pathways.
Feng C; Zhang J; Li X; Ai B; Han J; Wang Q; Wei T; Xu Y; Li M; Li S; Song C; Li C
Sci Rep; 2016 Sep; 6():33262. PubMed ID: 27625019
[TBL] [Abstract][Full Text] [Related]
2. Subpathway-GM: identification of metabolic subpathways via joint power of interesting genes and metabolites and their topologies within pathways.
Li C; Han J; Yao Q; Zou C; Xu Y; Zhang C; Shang D; Zhou L; Zou C; Sun Z; Li J; Zhang Y; Yang H; Gao X; Li X
Nucleic Acids Res; 2013 May; 41(9):e101. PubMed ID: 23482392
[TBL] [Abstract][Full Text] [Related]
3. ce-Subpathway: Identification of ceRNA-mediated subpathways via joint power of ceRNAs and pathway topologies.
Feng C; Song C; Ning Z; Ai B; Wang Q; Xu Y; Li M; Bai X; Zhao J; Liu Y; Li X; Zhang J; Li C
J Cell Mol Med; 2019 Feb; 23(2):967-984. PubMed ID: 30421585
[TBL] [Abstract][Full Text] [Related]
4. Subpathway-GMir: identifying miRNA-mediated metabolic subpathways by integrating condition-specific genes, microRNAs, and pathway topologies.
Feng L; Xu Y; Zhang Y; Sun Z; Han J; Zhang C; Yang H; Shang D; Su F; Shi X; Li S; Li C; Li X
Oncotarget; 2015 Nov; 6(36):39151-64. PubMed ID: 26472186
[TBL] [Abstract][Full Text] [Related]
5. The implications of relationships between human diseases and metabolic subpathways.
Li X; Li C; Shang D; Li J; Han J; Miao Y; Wang Y; Wang Q; Li W; Wu C; Zhang Y; Li X; Yao Q
PLoS One; 2011; 6(6):e21131. PubMed ID: 21695054
[TBL] [Abstract][Full Text] [Related]
6. Prioritization of rheumatoid arthritis risk subpathways based on global immune subpathway interaction network and random walk strategy.
Lv W; Wang Q; Chen H; Jiang Y; Zheng J; Shi M; Xu Y; Han J; Li C; Zhang R
Mol Biosyst; 2015 Nov; 11(11):2986-97. PubMed ID: 26289534
[TBL] [Abstract][Full Text] [Related]
7. Subpathway Analysis based on Signaling-Pathway Impact Analysis of Signaling Pathway.
Li X; Shen L; Shang X; Liu W
PLoS One; 2015; 10(7):e0132813. PubMed ID: 26207919
[TBL] [Abstract][Full Text] [Related]
8. Inference of patient-specific subpathway activities reveals a functional signature associated with the prognosis of patients with breast cancer.
Han J; Liu S; Jiang Y; Xu C; Zheng B; Jiang M; Yang H; Su F; Li C; Zhang Y
J Cell Mol Med; 2018 Sep; 22(9):4304-4316. PubMed ID: 29971923
[TBL] [Abstract][Full Text] [Related]
9. Inference of Subpathway Activity Profiles Reveals Metabolism Abnormal Subpathway Regions in Glioblastoma Multiforme.
Han X; Wang D; Zhao P; Liu C; Hao Y; Chang L; Zhao J; Zhao W; Mu L; Wang J; Li H; Kong Q; Han J
Front Oncol; 2020; 10():1549. PubMed ID: 33072547
[TBL] [Abstract][Full Text] [Related]
10. Identification of a robust subpathway-based signature for acute myeloid leukemia prognosis using an miRNA integrated strategy.
Chang H; Gao Q; Ding W; Qing X
PLoS One; 2018; 13(3):e0194245. PubMed ID: 29570744
[TBL] [Abstract][Full Text] [Related]
11. Identification of Subpathway Signatures For Ovarian Cancer Prognosis by Integrated Analyses of High-Throughput miRNA and mRNA Expression.
Tian S; Tian J; Chen X; Li L; Liu Y; Wang Y; Sun Y; Zhang C; Lou G
Cell Physiol Biochem; 2017; 44(4):1325-1336. PubMed ID: 29183027
[TBL] [Abstract][Full Text] [Related]
12. Identification of Cancer Dysfunctional Subpathways by Integrating DNA Methylation, Copy Number Variation, and Gene-Expression Data.
Liu S; Zheng B; Sheng Y; Kong Q; Jiang Y; Yang Y; Han X; Cheng L; Zhang Y; Han J
Front Genet; 2019; 10():441. PubMed ID: 31156704
[TBL] [Abstract][Full Text] [Related]
13. Identification of miRNA-Mediated Subpathways as Prostate Cancer Biomarkers Based on Topological Inference in a Machine Learning Process Using Integrated Gene and miRNA Expression Data.
Ning Z; Yu S; Zhao Y; Sun X; Wu H; Yu X
Front Genet; 2021; 12():656526. PubMed ID: 33841512
[TBL] [Abstract][Full Text] [Related]
14. Integrating gene and lncRNA expression to infer subpathway activity for tumor analyses.
Zhang C; Xu Y; Yang H; Xu Y; Dong Q; Liu S; Wu T; Zhang Y
Oncotarget; 2017 Dec; 8(67):111433-111443. PubMed ID: 29340065
[TBL] [Abstract][Full Text] [Related]
15. sPAGM: inferring subpathway activity by integrating gene and miRNA expression-robust functional signature identification for melanoma prognoses.
Zhang CL; Xu YJ; Yang HX; Xu YQ; Shang DS; Wu T; Zhang YP; Li X
Sci Rep; 2017 Nov; 7(1):15322. PubMed ID: 29127397
[TBL] [Abstract][Full Text] [Related]
16. Identifying subpathway signatures for individualized anticancer drug response by integrating multi-omics data.
Xu Y; Dong Q; Li F; Xu Y; Hu C; Wang J; Shang D; Zheng X; Yang H; Zhang C; Shao M; Meng M; Xiong Z; Li X; Zhang Y
J Transl Med; 2019 Aug; 17(1):255. PubMed ID: 31387579
[TBL] [Abstract][Full Text] [Related]
17. Comprehensive analysis of mRNA-level and miRNA-level subpathway activities for identifying robust ovarian cancer prognostic signatures.
Tian S; Mi W; Zhang M; Xing L; Zhang C
J Cell Mol Med; 2020 Feb; 24(4):2582-2592. PubMed ID: 31957240
[TBL] [Abstract][Full Text] [Related]
18. Computational Inferring of Risk Subpathways Mediated by Dysfunctional Non-coding RNAs.
Xu Y; Zhang Y; Li X
Adv Exp Med Biol; 2018; 1094():87-95. PubMed ID: 30191490
[TBL] [Abstract][Full Text] [Related]
19. psSubpathway: a software package for flexible identification of phenotype-specific subpathways in cancer progression.
Han J; Han X; Kong Q; Cheng L
Bioinformatics; 2020 Apr; 36(7):2303-2305. PubMed ID: 31821408
[TBL] [Abstract][Full Text] [Related]
20. LncSubpathway: a novel approach for identifying dysfunctional subpathways associated with risk lncRNAs by integrating lncRNA and mRNA expression profiles and pathway topologies.
Xu Y; Li F; Wu T; Xu Y; Yang H; Dong Q; Zheng M; Shang D; Zhang C; Zhang Y; Li X
Oncotarget; 2017 Feb; 8(9):15453-15469. PubMed ID: 28152521
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
